Satumomab pendetide: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Satumomab pendetide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
| Line 36: | Line 36: | ||
{{Mousemonoclonals}} | {{Mousemonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 15:53, 20 August 2012
Overview
Satumomab pendetide is a mouse monoclonal antibody and which it is used to treat cancer. Satumomab has a radioisotope, indium-111, and it has a chelator, pendetide.